Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adenocarcinoma, analyzed, basket, binding, chemotherapy, civil, Cohort, conclusion, consent, country, CT, description, digit, ELONA, Entry, exceed, excise, exploit, failed, failing, free, front, healthcare, IND, indemnification, industry, inflation, IRA, law, legislation, Lonza, low, Medicaid, Medicare, monetary, notice, passage, passed, patient, percentage, PFS, proprietary, purport, regimen, shown, single, SMILE, stable, submission, survival, uncured, unilaterally, unreasonably, verification, vivo, withheld, written
Removed:
ASC, decreased, Junior, PPP
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view